STOCK TITAN

Science 37®’s Operating System Receives ISO Certification for Information Security Management

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Neutral)
Tags

ISO 27001 certification and ISO 27701:2019 extension demonstrate Science 37’s commitment to quality, cybersecurity and privacy management

RESEARCH TRIANGLE PARK, N.C., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced its Operating System has earned ISO 27001 certification for cybersecurity management as well as the ISO 27701:2019 privacy management certification extension. These two certifications demonstrate Science 37’s continued commitment to embrace quality, robust cybersecurity, privacy and data protection rights.

“As the most complete Operating System for agile clinical trials, cybersecurity and privacy are of utmost importance in our aim to enable universal access,” said Anita Modi, Vice President of Business Transformation at Science 37. “These ISO certifications demonstrate that commitment across our unified technology platform, standardized processes and centralized networks while helping us drive improvements in our Privacy Information Management System.”

ISO 27001 certification is a globally recognized standard for the establishment and certification of an information security management system (ISMS). The standard specifies the requirements for establishing, implementing, operating, monitoring, reviewing, maintaining, and improving a documented ISMS. It sets forth a risk-based approach that focuses on security controls that protect information assets. The ISO 27701:2019 certification extension specifies the requirements for establishing, implementing, operating, monitoring, reviewing, maintaining, and improving a documented privacy information management system. Schellman & Company, LLC, an American National Standard Institute (ANSI) National Accreditation Board (ANAB) and United Kingdom Accreditation Board (UKAB) certified company performed the certifications. The ISMS certifications are publicly available at: https://www.schellman.com/certificate-directory.

“We know with today’s more agile clinical trial designs and decentralized approaches, sponsors, patients, regulators and sites need a dependable and trusted centralized Operating System to effectively execute studies and collect the requisite data at the highest level of quality,” said Ms. Modi. “These certifications are another step in helping show the dedication to cybersecurity and privacy that we all share at Science 37.”

About Science 37
Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to enable universal access to clinical research—making it easier for patients and providers to participate from anywhere and helping to accelerate the development of treatments that impact patient lives. As a pioneer of decentralized clinical trials, the Science 37 Agile Clinical Trial Operating System (OS) supports today’s more agile clinical research designs with its full stack, end-to-end technology platform and centralized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, provider communities, and data and devices. Configurable to enable almost any study type, the Science 37 OS enables up to 15x faster enrollment, 28% better retention and 3x more diverse patient population with industry-leading workflow orchestration, evidence generation and data harmonization. For more information, visit https://www.science37.com.

MEDIA INQUIRIES

Margie Kooman
Science 37
Phone: (984) 377-3737
Email: pr@science37.com

INVESTOR RELATIONS:
Caroline Paul
Gilmartin Group
Investors@science37.com


Science 37 Holdings Inc

NASDAQ:SNCE

SNCE Rankings

SNCE Latest News

SNCE Stock Data

Testing Laboratories
Professional, Scientific, and Technical Services
Link

About SNCE

science 37 uses advanced telemedicine technology and patient-centric innovative networked clinical research models to rapidly accelerate biomedical discovery and bring down the costs of clinical trials. in addition to our own researchers, we also work closely with top physician-scientists and leading telemedicine companies. s37 offers full support and end-to-end services for networked clinical trials. if you are an investigator, an inventor, a small biotech company or a large pharmaceutical company, we can help you achieve your clinical trial goals faster and easier than ever before. based in los angeles, we are focused on the development of networked patient-centric models for clinical research to rapidly accelerate biomedical discovery. we leverage partnerships with national mobile nursing companies, pharmacy chains, patient advocacy groups, virtual e-consenting, mobile devices, and other technology companies to maximize efficiency. then, using design-thinking principles and rapid pr